SLV-334 Uses, Dosage, Side Effects and more
SLV-334 is under investigation in clinical trial NCT00735085 (A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.).
| Attribute | Details |
|---|---|
| Trade Name | SLV-334 |
| Generic | SLV-334 |
| Type | |
| Formula | C33H36N2O6 |
| Weight | Average: 556.659 Monoisotopic: 556.257336887 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
